SCHEMBL21101185

SCHEMBL21101185

CCCCCCCC/C=C\CCCCCCCC(=O)NC1CCC2(C)C(CCC3C2CCC2(C)C3CCC2[C@H](C)CCC(=O)C(C)(C)C)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 2/20 0.52
▸ GPBAR1 Q8TDU6 4/20 0.51
▸ EPHA2 P29317 4/20 0.51
▸ VDR P11473 4/20 0.51
▸ HIF1A Q16665 3/20 0.51
▸ CYP3A4 P08684 2/20 0.51
▸ CYP2C9 P11712 2/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ CASP7 P55210 3/20 0.50
▸ TP53 P04637 2/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ BLM P54132 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ MDM4 O15151 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ HSPD1 P10809 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ PTPN2 P17706 1/20 0.50
▸ PTPN1 P18031 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19508253 1.00 USP2 (0.52) USP2GPBAR1EPHA2VDRHIF1A
SCHEMBL17612196 1.00 USP2 (0.52) USP2GPBAR1EPHA2VDRHIF1A
SCHEMBL9604589 1.00 USP2 (0.52) USP2GPBAR1EPHA2VDRHIF1A
SCHEMBL10177508 1.00 USP2 (0.52) USP2GPBAR1EPHA2VDRHIF1A
SCHEMBL19508252 1.00 USP2 (0.52) USP2GPBAR1EPHA2VDRHIF1A
SCHEMBL19772806 1.00 USP2 (0.52) USP2GPBAR1EPHA2VDRHIF1A
SCHEMBL9604432 0.93 USP2 (0.51) USP2GPBAR1EPHA2VDRHIF1A
SCHEMBL9604603 0.93 USP2 (0.51) USP2GPBAR1EPHA2VDRHIF1A
SCHEMBL18629132 0.92 USP2 (0.54) USP2GPBAR1EPHA2VDRHIF1A
SCHEMBL14978143 0.92 USP2 (0.54) USP2GPBAR1EPHA2VDRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10806791-B2 Carbohydrate conjugates as delivery agents for oligonucleotides ALNYLAM PHARMACEUTICALS, INC. (US) 2020-10-20 — — US disclosed
US-20190184018-A1 CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES BANK OF AMERICA, N.A. 2019-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190184018-A1 CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES SLC2A2, SLC2A8, SLC2A1 USP2 3449/4885GPBAR1 1180/4885EPHA2 260/4885
US-10806791-B2 Carbohydrate conjugates as delivery agents for oligonucleotides SLC2A2, SLC2A8, SLC2A1 USP2 3449/4885GPBAR1 1180/4885EPHA2 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback